FDA cliffhanger: Will Marty Makary stay or go?
Summary
Marty Makary, the FDA commissioner, was reported to be facing a possible firing by President Trump but appears to have kept his job for now. The FDA plays a big role in regulating many products and drugs in the U.S., and changes in leadership could affect decisions on drug approvals and policies.Key Facts
- The FDA regulates about one-fifth of the U.S. economy.
- Reports said President Trump had approved firing Makary, but he remained in his position last week.
- President Trump said he did not know about Makary’s possible firing.
- Some senior Health and Human Services officials reportedly wanted Makary removed.
- Makary has worked on issues like abortion pills, vaccine policies, and speeding up drug approvals.
- If Makary leaves, his replacement might be someone more accepted by the drug industry.
- FDA workforce has shrunk by over 19% in key areas since President Trump took office.
- Important drug decisions are upcoming, including treatments for cancer, ADHD, rare diseases, and an mRNA flu vaccine.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.